Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 47.82%2.25B | 16.12%1.52B | 1.66%1.31B | 29.17%1.29B | 8.02%997.42M | -2.86%923.34M | 9.37%950.51M | 14.10%869.04M | 18.59%761.63M | 13.92%642.26M |
| Revenue from customers | 47.82%2.25B | 16.12%1.52B | 1.66%1.31B | 29.17%1.29B | 7.86%997.42M | -3.34%924.75M | 9.81%956.72M | 14.06%871.23M | 18.44%763.85M | 13.80%644.94M |
| Other cash income from operating activities | ---- | ---- | ---- | ---- | ---- | 77.34%-1.41M | -184.60%-6.21M | 1.58%-2.18M | 17.28%-2.22M | 9.00%-2.68M |
| Cash paid | -80.42%-1.32B | -11.99%-732.2M | -10.31%-653.8M | -25.58%-592.7M | -17.48%-471.97M | 8.78%-401.74M | -6.90%-440.42M | -14.97%-411.99M | -13.14%-358.36M | -9.94%-316.73M |
| Payments to suppliers for goods and services | -80.42%-1.32B | -11.99%-732.2M | -10.31%-653.8M | -25.58%-592.7M | -17.48%-471.97M | 8.78%-401.74M | -6.90%-440.42M | -14.97%-411.99M | -13.14%-358.36M | -9.94%-316.73M |
| Direct interest paid | 58.47%-10.3M | -43.35%-24.8M | -136.99%-17.3M | -19.79%-7.3M | 13.65%-6.09M | 35.30%-7.06M | 8.55%-10.91M | 14.19%-11.93M | -169.10%-13.9M | -3,148.43%-5.17M |
| Direct interest received | -0.82%12.1M | 69.44%12.2M | 453.85%7.2M | -47.33%1.3M | -11.38%2.47M | 56.29%2.79M | -66.78%1.78M | 112.48%5.37M | 33.67%2.53M | -55.06%1.89M |
| Direct tax refund paid | -35.87%-253.8M | -7.85%-186.8M | 14.30%-173.2M | -0.86%-202.1M | -104.10%-200.38M | 28.29%-98.18M | -10.28%-136.91M | -30.57%-124.14M | 5.78%-95.08M | -14.22%-100.91M |
| Operating cash flow | 14.59%675.4M | 24.69%589.4M | -3.06%472.7M | 51.69%487.6M | -23.31%321.45M | 15.13%419.15M | 11.55%364.05M | 9.95%326.35M | 34.10%296.82M | 15.67%221.34M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 134.65%71.1M | -53.59%-205.2M | 31.38%-133.6M | 48.97%-194.7M | -277.10%-381.52M | -56.28%-101.17M | 82.60%-64.74M | -794.92%-372.1M | 109.41%53.55M | -103.64%-568.88M |
| Net PPE purchase and sale | -50.00%-6.3M | 44.00%-4.2M | 1.32%-7.5M | -180.44%-7.6M | 74.98%-2.71M | -169.81%-10.83M | 52.31%-4.01M | 27.84%-8.42M | -203.20%-11.66M | 72.59%-3.85M |
| Net intangibles purchas and sale | -9.02%-131.7M | -9.72%-120.8M | -25.97%-110.1M | -36.08%-87.4M | -2.72%-64.23M | 2.23%-62.52M | -25.76%-63.95M | -19.67%-50.85M | -17.43%-42.49M | -30.50%-36.18M |
| Net business purchase and sale | 13.20%-61.8M | -7,020.00%-71.2M | -350.00%-1M | 100.15%400K | -1,518.65%-267.39M | -610.79%-16.52M | 101.05%3.23M | -273.65%-307.8M | 134.65%177.25M | -18,414.80%-511.56M |
| Net investment purchase and sale | 3,560.53%263M | 49.33%-7.6M | 85.01%-15M | -182.85%-100.1M | -213.19%-35.39M | -125,455.56%-11.3M | 99.82%-9K | 92.76%-5.04M | -302.29%-69.55M | 92.64%-17.29M |
| Net other investing changes | --7.9M | ---- | ---- | ---- | ---11.81M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 134.65%71.1M | -53.59%-205.2M | 31.38%-133.6M | 48.97%-194.7M | -277.10%-381.52M | -56.28%-101.17M | 82.60%-64.74M | -794.92%-372.1M | 109.41%53.55M | -103.64%-568.88M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -18.71%-521.6M | -33.43%-439.4M | -50.09%-329.3M | -1,964.54%-219.4M | 105.04%11.77M | 15.91%-233.52M | -40.56%-277.7M | -67.12%-197.56M | -129.91%-118.21M | 554.15%395.25M |
| Net issuance payments of debt | -9.40%-210.6M | -90.59%-192.5M | -1,074.42%-101M | -105.18%-8.6M | 315.84%166.13M | 37.26%-76.97M | -91.68%-122.68M | -1,500.00%-64M | -100.80%-4M | --498M |
| Net common stock issuance | -4.09%-22.9M | -161.90%-22M | 47.50%-8.4M | -329.99%-16M | -981.69%-3.72M | 41.40%-344K | 86.02%-587K | -232.91%-4.2M | 25.03%-1.26M | 10.77%-1.68M |
| Cash dividends paid | -24.68%-280.4M | -3.59%-224.9M | -11.68%-217.1M | -29.05%-194.4M | 3.56%-150.64M | -1.15%-156.21M | -19.38%-154.43M | -14.53%-129.37M | -11.76%-112.95M | -18.70%-101.07M |
| Net other financing activities | ---7.7M | ---- | -600.00%-2.8M | ---400K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -18.71%-521.6M | -33.43%-439.4M | -50.09%-329.3M | -1,964.54%-219.4M | 105.04%11.77M | 15.91%-233.52M | -40.56%-277.7M | -67.12%-197.56M | -129.91%-118.21M | 554.15%395.25M |
| Net cash flow | ||||||||||
| Beginning cash position | -21.40%204.2M | 4.67%259.8M | 46.95%248.2M | -24.21%168.9M | 61.60%222.85M | 19.04%137.9M | -67.69%115.84M | 182.65%358.5M | 60.77%126.83M | -68.91%78.89M |
| Current changes in cash | 507.43%224.9M | -663.27%-55.2M | -86.67%9.8M | 252.16%73.5M | -157.20%-48.31M | 290.62%84.46M | 108.89%21.62M | -204.81%-243.32M | 386.62%232.15M | 127.26%47.71M |
| Effect of exchange rate changes | 175.00%300K | -122.22%-400K | 100.00%1.8M | 215.09%900K | -259.27%-782K | 12.87%491K | -34.29%435K | 237.34%662K | -305.98%-482K | 72.06%234K |
| Cash adjustments other than cash changes | ---600K | ---- | ---- | 200.25%4.9M | ---4.89M | ---- | ---- | ---- | ---- | ---- |
| End cash Position | 109.99%428.8M | -21.40%204.2M | 4.67%259.8M | 46.98%248.2M | -24.22%168.87M | 61.60%222.85M | 19.04%137.9M | -67.69%115.84M | 182.65%358.5M | 60.77%126.83M |
| Free cash from | 15.72%537.4M | 30.78%464.4M | -9.55%355.1M | 54.25%392.6M | -26.40%254.52M | 16.79%345.79M | 10.86%296.09M | 10.06%267.08M | 33.84%242.66M | 21.27%181.31M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |